Boehringer Ingelheim to Shift to Independent Marketing in Japan for Upcoming New Products

Engelbert Tjeenk Willink, Corporate Board Division, Marketing and Sales, Boehringer Ingelheim of Germany Boehringer Ingelheim (BI) of Germany will independently market new products, which it plans to launch in Japan in the future, in fields including cancer and hepatitis C...read more